ADCendo is a Biotech company based in Copenhagen, Denmark. It has raised $62M in total funding. Latest round: Series A.
ADCendo funding overview
ADCendo is a Biotech company based in Copenhagen, Denmark. ADCendo has raised $62M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for ADCendo runs through 2021; nothing later has been disclosed. Investors on record include Novo Seeds, Ysios Capital, RA Capital Management, HealthCap, Gilde Healthcare. 5 distinct backers are named across the disclosed rounds.
ADCendo at a glance
Total raised
$62M
Latest round
Series A
Latest round date
April 2021
Industry
Biotech
Headquarters
Copenhagen, Denmark
Notable investors
Novo Seeds, Ysios Capital, RA Capital Management, HealthCap, Gilde Healthcare
Frequently asked about ADCendo funding
How much has ADCendo raised?
ADCendo has raised $62M in total disclosed funding across the rounds on record.
Who has invested in ADCendo?
Novo Seeds, Ysios Capital, RA Capital Management, HealthCap, Gilde Healthcare are named among the investors backing ADCendo.
What was the latest ADCendo funding round?
The most recent disclosed round is a Series A, announced in April 2021.
Where is ADCendo based?
ADCendo is based in Copenhagen, Denmark.
What sector does ADCendo operate in?
ADCendo is tracked under Biotech from Copenhagen, Denmark, with $62M in disclosed funding.
When did ADCendo last raise?
The last disclosed ADCendo round closed in April 2021 at Series A.
We update the ADCendo record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Copenhagen and their backers are listed below.
